Back to top

Arbutus Biopharma Reshapes Strategy After Moderna Settlement

Arbutus Biopharma ( ($ABUS) ) has provided an announcement. In March 2026, Arbutus, Genevant and Moderna entered a global patent litigation settlem...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Arbutus Biopharma Corporation (ABUS)